Background {#Sec1}
==========

Systematic reviews (SRs) summarise and synthesise randomised controlled trials (RCTs), the best method for testing interventions, to produce high levels of evidence. Cochrane is an organisation committed to generating the highest level of evidence by systematically reviewing the medical literature \[[@CR1]\]. It comprises 53 editorial groups. The Cochrane Acute Respiratory Infections Group (CARIG) focuses on reviewing and summarising the evidence of treatments for acute respiratory infections (ARIs) \[[@CR2]\]. ARIs carry a large burden of disease \[[@CR3]\].

Cochrane reviews are among the most rigorous forms of systematic review \[[@CR4]\] and, accordingly, require the greatest editorial support provided by the Cochrane ARI Group. They typically take 6 months to 2 years to complete \[[@CR5], [@CR6]\]. Not all potential titles submitted can be supported, and so, a priority-setting process is necessary. \[[@CR7]--[@CR10]\]. As part of the CARIG's priority-setting process, we resolved to determine interventions and health conditions for which there are RCTs not systematically reviewed by Cochrane.

Methods {#Sec2}
=======

Study selection and categorisation {#Sec3}
----------------------------------

We exported Cochrane reviews specific to the CARIG by interrogating Cochrane's management software ('Archie'), equivalent to searching the Cochrane Database of Systematic Reviews (CDSR) Issue 9 of 12, September 2014. We also exported a list of ARI-specific RCTs from the CARIG trials register (the date range of trials was 1930 to 2014). Both exports were done on the 9th of September 2014. Both lists were imported via a reference manager (EndNote) into a spreadsheet where two authors (JA and SV) independently examined the titles (and if necessary, abstracts) to classify the main interventions and health conditions (together forming a 'topic'). Disagreements were settled by consensus or resolved by a third author (CDM).

We sorted CRs and RCTs by topic (the same intervention and health condition) and then matched CRs and RCTs with the same topic (or paired intervention and health condition). This process enabled us to identify the CRs and RCTS where a match was made on the same topic (intervention and health condition matched) and where there were existing RCTs on particular topics (intervention and health condition) but no CRs. We also identified where there were CRs on particular topics but no RCTs (empty reviews).

Studies that did not consistently cover a single disease or intervention {#Sec4}
------------------------------------------------------------------------

For each CR or RCT, the intervention was classified followed by the health condition. Where more than one health condition and/or intervention was represented in a single CR or RCT, all health conditions and interventions were classified.

Resolving categorisation discrepancies {#Sec5}
--------------------------------------

Once all studies had been assigned an intervention and health condition, the categories were checked for consistency. Where appropriate, categories were merged together (e.g. the physiotherapy and exercise categories were merged into a single category called 'physiotherapy/exercise'). Medical and common terms (e.g. 'pharyngitis' and 'sore throat') were also combined into a single category.

Results {#Sec6}
=======

Out of 162 Cochrane reviews screened, 5 were excluded as they were either withdrawn or out of date, leaving 157 for inclusion. Out of 5393 RCT titles screened, 108 were excluded due to not addressing an ARI, had no intervention or were not an RCT, leaving 5285. Of these 409, required reading the abstract and, or, full text.

We initially listed 54 Cochrane review intervention categories, which we merged into 45, and 35 health condition categories were merged into 27. Similarly, 377 RCT intervention categories were merged to 182, and 168 health condition categories to 101.

The most common topics systematically reviewed by the CARIG were *antibiotics for pneumonia* (11 CRs, 6.4% of the total); *vaccination for influenza* (*n* = 6, 3.5%); *vaccination for pertussis* (*n* = 4, 2.3%); *antiviral drugs for influenza* (*n* = 4, 2.3%); *antibiotics for otitis media* (*n* = 4, 2.3%); and *antibiotics for sore throat* (*n* = 4, 2.3%) (Table [1](#Tab1){ref-type="table"}). The most common interventions reviewed by the CARIG is *antibiotic vs placebo* (5 out of the top 10 most common topics). The topics which had been the focus of the most RCTS were *vaccinations for influenza* (525, 7.7%); *vaccination for pertussis* (303, 4.4%); and *antibiotic vs antibiotic for pneumonia* (269, 4%) (Table [2](#Tab2){ref-type="table"}). The most commonly occurring intervention in the ARI trials register was *vaccination* (6 out of the top 10 most common topics). However, *antibiotic vs antibiotic* in general was the least common intervention Cochrane reviewed (only 1, 0.6%).Table 1Number of CRs and RCTs ranked by number of CRsInterventionHealth conditionNo. of RCTsNo. of CRsAntibiotic vs placeboPneumonia20511VaccinationInfluenza5256VaccinationPertussis3034AntiviralInfluenza1474Antibiotic vs placeboOtitis media1144Antibiotic vs placeboPharyngitis/sore throat904Antibiotic vs placeboARI non-specific1293CAMCommon cold443Antibiotic vs placeboMeningitis363VaccinationDiphtheria2462VaccinationTetanus2362VaccinationMeasles1612VaccinationPneumococcus1432Antibiotic vs placeboBronchitis, acute602VaccinationHepatitis582CAMARI non-specific492AntiviralHerpes zoster432Antibiotic vs placeboBronchiolitis422AntihistamineCommon cold412CorticosteroidMeningitis392Antitussive/decongestant/expectorantCough362VaccinationOtitis media352VaccinationHerpes zoster302Antibiotic vs placeboCommon cold212CAMInfluenza182 Table 2Number of CRs and RCTs ranked by number of RCTsInterventionHealth conditionNo. of RCTsNo. of CRsVaccinationInfluenza5256VaccinationPertussis3034Antibiotic vs antibioticPneumonia2690VaccinationDiphtheria2462VaccinationTetanus2362Antibiotic vs placeboPneumonia20511VaccinationCroup1881VaccinationMeasles1612AntiviralInfluenza1474Antibiotic vs antibioticBronchitis, acute1460VaccinationPneumococcus1432Antibiotic vs antibioticPharyngitis/sore throat1400Antibiotic vs antibioticOtitis media1350Antibiotic vs placeboARI non-specific1293VaccinationMeningitis1161Antibiotic vs placeboOtitis media1144Antibiotic vs antibioticARI non-specific1060Antibiotic vs placeboPharyngitis/sore throat904VaccinationMumps861Antibiotic vs antibioticSinusitis820VaccinationRubella801VaccinationPolio670ImmunotherapyARI non-specific651Antibiotic vs placeboBronchitis, acute602Antibiotic vs placeboSinusitis601

There were many RCTs with no corresponding CRs (2174 or 41%) (Table [3](#Tab3){ref-type="table"}). Most used the intervention of *antibiotics*, which accounts for 878 RCTs (12.8%). Similarly, there were (only) 6 CRs which reviewed no RCTs (that is they were 'empty reviews') (Table [4](#Tab4){ref-type="table"}).Table 3RCTs with no CR ranked by number of RCTsInterventionHealth conditionNo. of RCTsNo. of CRsAntibiotic vs antibioticPneumonia2690Antibiotic vs antibioticBronchitis, acute1460Antibiotic vs antibioticPharyngitis/sore throat1400Antibiotic vs antibioticOtitis media1350Antibiotic vs antibioticARI non-specific1060Antibiotic vs antibioticSinusitis820VaccinationPolio670Antibiotic vs antibioticBronchiolitis530NSAIDARI non-specific360ImmunotherapyCommon cold340NSAIDPharyngitis/sore throat310AntiviralCommon cold270VaccinationHerpes simplex250Vitamin AARI non-specific230Antitussive/decongestantOtitis media230Vitamins and supplementsARI non-specific190Antibiotic vs placeboStaphylococcus190VaccinationARI non-specific180CAMBronchiolitis170Vaccination reminderInfluenza170Humidification/steamPneumonia160AntiviralRespiratory syncytial virus160VaccinationRespiratory syncytial virus150Antibiotic vs antibioticStaphylococcus150Antibiotic vs antibioticStreptococcus140 Table 4CRs with no RCTs (empty reviews)InterventionHealth conditionNo. of RCTsNo. of CRsZincOtitis media01AcupunctureMumps01CAMBronchitis, acute01CAMMumps01Fluid therapyARI non-specific01Nasal irrigationARI non-specific01

We devised a novel method of representing the extensive relationship between CRs and RCTs, which conveys the information in Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} that allows the user to interact with the data (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). This is an interactive online graph available from our website \[[@CR11]\].Fig. 1Graphical representation of CRs mapped to RCTs overview. *Colours* are used to identify the same interventions, for instance *blue*, as seen here, represents *vaccination*. In the live version, users can select the topic of interest by passing the mouse over it, which will expand the number of RCTs and CRs associated with that topic. The figure shows a static sub-section of the graph at <http://crebp.github.io/CREBP-Disease-Treatment/> Fig. 2Graphical representation of Cochrane review mapped to RCTs (*antibiotic vs antibiotic*). This static screenshot shows the effects of a reader's mouse over an intervention which is covered by a Cochrane review (here, *antibiotic vs antibiotic*): the right side of the figure expands to show the diseases for which *antibiotic vs antibiotic* has been studied Fig. 3Graphical representation of Cochrane reviews mapped to RCTs (no CR, vaccination reminder). In this example, there is an intervention (*vaccination reminders*) with RCTs but no corresponding Cochrane review (a 'review gap'). The RCT section has expanded to show the topics with available evidence that could be incorporated into a Cochrane review. The Cochrane review section is empty

Discussion {#Sec7}
==========

We found many topics which have been trialled but not reviewed, consistent with the previous findings \[[@CR12]\]. These data should allow the CARIG to identify clinical questions in need of review.

The topic with the most Cochrane reviews was *antibiotics for pneumonia*. Pneumonia makes an important contribution to the burden of disease worldwide, especially in the developing world \[[@CR3]\], and so, this over-representation seems appropriate. The interventions trialled with least representation with CRs, *antibiotic vs antibiotic*, are often driven by pharmaceutical companies (interested in demonstrating that a new member of an existing antibiotic class has equivalent efficacy), something perhaps less interesting to clinicians.

Strengths of our methods were the exploitation of the set of trials already collected by Cochrane and the collection of CRs and our matching methods and online visualisation techniques. Weaknesses include the limitation to CRs (there are undoubtedly other systematic reviews outside Cochrane), the potentially arbitrary over-simplification of the topics to one or two interventions for each health condition category and our limitation to treatment questions (Cochrane has a minority of diagnostic reviews as well)---nor did we account for 'stabilised reviews' (those in which the intervention is no longer current, e.g. *amantadine and rimantadine for influenza* \[[@CR13]\] or where there is sufficient evidence to settle for a clinical question), e.g. *vaccination to prevent polio* \[[@CR14]\].

Conclusions {#Sec8}
===========

These data will inform our forthcoming priority-setting exercise during which they will be presented to stakeholders (health consumers and clinicians) to allow judgement to be made about which topics should be given higher priority.
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